• Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Sign in / Register
  • Subscribe
Search our site
Menu
Close menu
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
    • Back to parent navigation item
    • Topics
    • Early Career Research
    • One Health
    • Food Security
    • Climate Action
    • Healthy Land
    • Clean Water
    • Economic Equality
    • Ocean Sustainability
  • Regions
    • Back to parent navigation item
    • Regions
    • Africa & Middle East
    • Asia & Oceania
    • The Americas
    • UK & Europe
    • USA & Canada
  • Videos
  • AMI
    • Back to parent navigation item
    • AMI
    • Community
    • Policy
    • Publishing
    • Events
    • Special Issues
    • Diversity & Inclusion
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
      • Early Career Research
      • One Health
      • Food Security
      • Climate Action
      • Healthy Land
      • Clean Water
      • Economic Equality
      • Ocean Sustainability
  • Regions
      • Africa & Middle East
      • Asia & Oceania
      • The Americas
      • UK & Europe
      • USA & Canada
  • Videos
  • AMI
      • Community
      • Policy
      • Publishing
      • Events
      • Special Issues
      • Diversity & Inclusion
  • More from navigation items

Latest news

Fetus_and_placenta_-_journal.pbio.0060312.g001

Albumin is prevented from crossing the placenta – opening opportunities for design of long-acting biologic medicines

2026-08-17T14:56:00+01:00

Researchers have uncovered that the placenta distinguishes between antibodies and albumin, a finding that may reshape the future design of biologic medicines with reduced fetal exposure.  

Hydrogels

Cell ‘invisibility cloaks’ could offer side-effect-free diabetes treatment

2026-08-17T14:08:00+01:00

New research suggests manufacturing cells an “invisibility cloak” out of a jelly-like material known as hydrogel, may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy.

Antiretroviral_Drugs_to_Treat_HIV_Infection_(32483530942)

UC San Diego receives $12.3 million grant to study the intersection of HIV and methamphetamine use

2026-08-17T13:37:00+01:00

A newly funded programme aims to use a multidisciplinary approach focused on improving the clinical care and brain health of people with HIV who also have an active methamphetamine use disorder.

Solo-mrna-vaccine-5

Stable RNA elements open new possibilities for mRNA therapeutics

2026-08-17T13:07:00+01:00

New research has discovered compact viral RNA elements that can make mRNA more stable, and could provide a simple way to develop longer-lasting and more efficient mRNA technologies for vaccines and other RNA-based therapeutics. 

Iron_electrolytic_and_1cm3_cube

Cells use a little-known molecule to protect themselves from iron overload

2026-08-17T12:49:00+01:00

New research shows that cells rely on an unexpected protector against elevated iron levels: small molecules called polyamines. These small molecules act like storage lockers for iron, safely holding the metal in a non-reactive state until cells need it.

Varbuss

Could beneficial bacteria help prevent the body from absorbing lead?

2026-08-17T12:23:00+01:00

New funding supports early-stage research at Worcester Polytechnic Institute that aims to show how pieces of genetic code produced in the gut by healthy bacteria could block lead exposure.

All news content

Research

Fetus_and_placenta_-_journal.pbio.0060312.g001

Albumin is prevented from crossing the placenta – opening opportunities for design of long-acting biologic medicines

2026-08-17T14:56:00+01:00

Researchers have uncovered that the placenta distinguishes between antibodies and albumin, a finding that may reshape the future design of biologic medicines with reduced fetal exposure.  

Antiretroviral_Drugs_to_Treat_HIV_Infection_(32483530942)

UC San Diego receives $12.3 million grant to study the intersection of HIV and methamphetamine use

2026-08-17T13:37:00+01:00

A newly funded programme aims to use a multidisciplinary approach focused on improving the clinical care and brain health of people with HIV who also have an active methamphetamine use disorder.

Solo-mrna-vaccine-5

Stable RNA elements open new possibilities for mRNA therapeutics

2026-08-17T13:07:00+01:00

New research has discovered compact viral RNA elements that can make mRNA more stable, and could provide a simple way to develop longer-lasting and more efficient mRNA technologies for vaccines and other RNA-based therapeutics. 

More Research

Industry

Korean_cuisine-Kimchi-08

Genome-scale model-guided microbial engineering converts agricultural waste into biodegradable bioplastics

2026-08-17T10:46:00+01:00

Researchers develop a genome-scale model-guided microbial engineering platform that converts kimchi industry waste into biodegradable bioplastics.

Loading_bioreactor

Industrial-scale biotech production of proteins and vitamins economically viable

2026-08-17T09:21:00+01:00

Researchers are developing biotechnological methods called “power-to-protein” and “power-to-vitamin” processes which use microbes to produce proteins and vitamins for human consumption using basic chemical ingredients – entirely bypassing livestock farming and agriculture.

HIV-infected_H9_T_Cell_(6813314147)

Long-acting therapies continue to gain momentum in HIV, says GlobalData

2026-08-11T12:18:00+01:00

The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but improving treatment adherence, reducing medication burden and delivering more convenient treatment options, says a new analysis.

more industry

Innovation

Hydrogels

Cell ‘invisibility cloaks’ could offer side-effect-free diabetes treatment

2026-08-17T14:08:00+01:00

New research suggests manufacturing cells an “invisibility cloak” out of a jelly-like material known as hydrogel, may offer an easier, less damaging treatment pathway for people with diabetes undergoing cell therapy.

Low-Res_IMG_8674

Scientists reconstruct past ocean temperatures from red algae

2026-08-12T09:19:00+01:00

Researchers have found a new way to reconstruct daily seawater temperatures over a four-month period. The key lies in rhodoliths: nodule-like calcareous structures formed by red algae that occur in oceans worldwide. 

Plphys_v161_3_1334_f1b-via-RG

Long-lasting and renewable chemical production using photosynthetic microorganisms

2026-08-11T12:08:00+01:00

Researchers have taken an important step toward long-lasting production of renewable chemicals and fuels using photosynthetic microorganisms.

more innovation

People

Varbuss

Could beneficial bacteria help prevent the body from absorbing lead?

2026-08-17T12:23:00+01:00

New funding supports early-stage research at Worcester Polytechnic Institute that aims to show how pieces of genetic code produced in the gut by healthy bacteria could block lead exposure.

Low-Res_Heather Kelly

Plant pathologist selected as Fulbright Distinguished Scholar

2026-08-13T08:44:00+01:00

Heather Kelly, field crops pathologist in the University of Tennessee Department of Entomology and Plant Pathology, has received a prestigious Fulbright Distinguished Scholar Award for two one-month trips to Brazil in 2026 and 2027. 

Bordetella_pertussis_on_Charcoal_Agar_supplemented_with_Cephalexin_-_Detail

U.S. disease tracker launches to strengthen monitoring of vaccine-preventable diseases

2026-08-06T10:09:00+01:00

A new website will track the spread of vaccine-preventable diseases across the United States to offer the public, the media, healthcare providers, public health officials, and policymakers reliable and visual information about current disease trends.

more people

  • Issues
  • Contact us
  • Topics A-Z
  • Writers A-Z
  • Advertise with us
  • Editorial Team
  • In the Loop Newsletter

Bringing the international microbiology community together to advance scientific impact.
appliedmicrobiology.org

© Applied Microbiology International
  • Cookie Policy
  • Privacy
  • Terms of use
  • © 2022 The Microbiologist

Site powered by Webvision Cloud